[Retracted] Analysis of Coagulation Abnormality in Patients with Multiple Myeloma and Its Clinical Significance

Table 2

Univariate analysis of prognosis in patients with MM.

Factor	Survival (n = 61)	Death (n = 19)	χ^2
Gender			0.373	0.542
Male	37 (60.66%)	13 (68.42%)
Female	24 (39.34%)	6 (31.58%)
Age (years)			0.370	0.543
≥60	21 (34.43%)	8 (42.11%)
<60	40 (65.57%)	11 (57.89%)
DS staging			0.964	0.618
I	6 (9.84%)	3 (15.79%)
II	11 (18.03%)	2 (10.53%)
III	44 (2.13%)	14 (73.68%)
PT (s)	12.25 ± 1.04	14.93 ± 0.75	10.401	<0.001
APTT (s)	33.18 ± 4.99	39.04 ± 3.57	4.745	<0.001
FIB (g/L)	2.83 ± 0.65	2.65 ± 0.50	1.108	0.272
TT (s)	14.35 ± 3.74	15.19 ± 3.87	0.848	0.399
D-D (μg/ml)	2.07 ± 1.41	0.81 ± 0.17	3.870	<0.001
PLT (×10^9/L)	165.07 ± 36.07	175.80 ± 35.10	1.139	0.258